0001209191-21-003245.txt : 20210112
0001209191-21-003245.hdr.sgml : 20210112
20210112163548
ACCESSION NUMBER: 0001209191-21-003245
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210108
FILED AS OF DATE: 20210112
DATE AS OF CHANGE: 20210112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buck Jill
CENTRAL INDEX KEY: 0001780426
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33038
FILM NUMBER: 21523901
MAIL ADDRESS:
STREET 1: C/O ZIOPHARM ONCOLOGY, INC.
STREET 2: ONE FIRST AVENUE, PARRIS BUILDING 34
CITY: BOSTON
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZIOPHARM ONCOLOGY INC
CENTRAL INDEX KEY: 0001107421
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841475642
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE FIRST AVENUE
STREET 2: PARRIS BUILDING 34, NAVY YARD PLAZA
CITY: BOSTON
STATE: MA
ZIP: 02129
BUSINESS PHONE: 617-259-1970
MAIL ADDRESS:
STREET 1: ONE FIRST AVENUE
STREET 2: PARRIS BUILDING 34, NAVY YARD PLAZA
CITY: BOSTON
STATE: MA
ZIP: 02129
FORMER COMPANY:
FORMER CONFORMED NAME: EASYWEB INC
DATE OF NAME CHANGE: 20010213
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-08
0
0001107421
ZIOPHARM ONCOLOGY INC
ZIOP
0001780426
Buck Jill
ONE FIRST AVENUE, PARRIS BUILDING 34
NAVY YARD PLAZA
BOSTON
MA
02129
0
1
0
0
EVP, GM Gene Therapy
Common Stock
2021-01-08
4
S
0
27894
3.12
D
199516
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.035 to $3.205, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Robert Hadfield, Attorney-in-Fact
2021-01-12